v3.26.3
Net Income (Loss) Per Share (Details) - $ / shares
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Mar. 31, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Number of shares converted in to notes 2,222,222 2,222,222    
Number of shares converted in to option 3,702,260     3,702,360
Exercise price (in Dollars per share) $ 15     $ 15
March 2025 Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Warrants outstanding 925,590     925,590
FTAC Emerald [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Warrants exercisable 12,434,658   12,434,658  
Exercise price (in Dollars per share) $ 11.5   $ 11.5  
Series A [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Warrants exercisable 869,565 869,565    
Exercise price (in Dollars per share)   $ 12.5    
Series C [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Warrants exercisable 12.5 869,565    
Exercise price (in Dollars per share) $ 9 $ 9    
Series B [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Warrants exercisable 869,565